Cited by 107Lipoproteins and Cardiovascular HealthLipid metabolism and disordersCholesterol and Lipid Metabolism

The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.

Remnant lipoproteins as therapeutic targets

Havel, Richard J.·2000·Current Opinion in Lipidology

DOI 10.1097/00041433-200012000-00008

Open this paper in CoChat — free account

Abstract

Increasing evidence suggests that subsets of triglyceride-rich lipoproteins are particularly atherogenic. These include particles with some, but not necessarily all the properties classically attributed to remnants. Cholesteryl ester-enrichment seems to be a common feature of these particles, some of which can be taken up by macrophages by a novel receptor that recognizes species of apolipoprotein B but not apolipoprotein E. These characteristics seem to be common to postprandial and hypertriglyceridemic very low density lipoproteins as well as chylomicron remnants. Remnant-like triglyceride-rich lipoproteins that exhibit several potentially atherogenic properties can be quantified by a simple test that shows promise for identifying individuals at high risk for lesion formation and clinical events. Available hygienic and pharmaceutical measures that effectively lower the concentration of atherogenic triglyceride-rich lipoproteins deserve wider use.

Integrity signals

Registry

Crossref · 10.1097/00041433-200012000-00008

Cites

59 of 59 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Atherogenesis: a postprandial phenomenon.
Zilversmit, D. B. (1979) · Circulation · doi:10.1161/01.cir.60.3.473 · Cited by 1,701
Plasma cholesteryl ester transfer protein
Tall, A. (1993) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)36957-1 · Cited by 953
Plasminogen-Activator Inhibitor Type 1 and Coronary Artery Disease
Kohler, H. P., & Grant, P. J. (2000) · New England Journal of Medicine · doi:10.1056/nejm200006153422406 · Cited by 805
Cholesterol in remnant-like lipoproteins in human serum using monoclonal anti apo B-100 and anti apo A-I immunoaffinity mixed gels
Nakajima, K., SAITO, T., Tamura, A., Suzuki, M., Nakano, T., Adachi, M., Tanaka, A., Tada, N., Nakamura, H., Campos, E. M., et al. (1993) · Clinica Chimica Acta · doi:10.1016/0009-8981(93)90062-9 · Cited by 417
Self-citation
Apoprotein composition of very low density lipoproteins of human serum.
Kane, J. P., Sata, T., Hamilton, R. L., & Havel, R. J. (1975) · Journal of Clinical Investigation · doi:10.1172/jci108245 · Cited by 376
Self-citation
Postprandial lipoprotein metabolism and atherosclerosis.
Karpe, F. (1999) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.1999.00548.x · Cited by 360
Characterization of subfractions of triglyceride-rich lipoproteins separated by gel chromatography from blood plasma of normolipemic and hyperlipemic humans
Sata, T., Havel, R. J., & Jones, A. L. (1972) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)39346-9 · Cited by 359
Self-citation
Relation of Lipoprotein Subclasses as Measured by Proton Nuclear Magnetic Resonance Spectroscopy to Coronary Artery Disease
Freedman, D. S., Otvos, J. D., Jeyarajah, E. J., Barboriak, J. J., Anderson, A. J., & Walker, J. A. (1998) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.18.7.1046 · Cited by 345
Characterization of remnants produced during the metabolism of triglyceride-rich lipoproteins of blood plasma and intestinal lymph in the rat.
Mjøs, O. D., Færgeman, O., Hamilton, R. L., & Havel, R. J. (1975) · Journal of Clinical Investigation · doi:10.1172/jci108130 · Cited by 322
Self-citation
Remnant Lipoprotein Levels in Fasting Serum Predict Coronary Events in Patients With Coronary Artery Disease
Kugiyama, K., Doi, H., Takazoe, K., Kawano, H., Soejima, H., Mizuno, Y., Tsunoda, R., Sakamoto, T., Nakano, T., Nakajima, K., et al. (1999) · Circulation · doi:10.1161/01.cir.99.22.2858 · Cited by 284
Relationships between the responses of triglyceride-rich lipoproteins in blood plasma containing apolipoproteins B-48 and B-100 to a fat-containing meal in normolipidemic humans.
Schneeman, B. O., Kotite, L., Todd, K., & Havel, R. J. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.5.2069 · Cited by 255
Self-citation
Characterization of human very low density lipoproteins containing two electrophoretic populations: double pre-beta lipoproteinemia and primary dysbetalipoproteinemia
Pagnan, A., Havel, R. J., Kane, J. P., & Kotite, L. (1977) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41603-7 · Cited by 236
Self-citation
Primary Dysbetalipoproteinemia: Predominance of a Specific Apoprotein Species in Triglyceride-Rich Lipoproteins
Havel, R. J., & Kane, J. P. (1973) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.70.7.2015 · Cited by 231
Self-citation
Atherogenicity of Triglyceride-Rich Lipoproteins
Krauss, R. M. (1998) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00032-0 · Cited by 227
Secretion-capture role for apolipoprotein E in remnant lipoprotein metabolism involving cell surface heparan sulfate proteoglycans.
Ji, Z. S., Fazio, S., Lee, Y. L., & Mahley, R. W. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)42009-6 · Cited by 211
Postprandial hyperlipidemia and remnant lipoproteins.
Havel, R. J. (1994) · Current Opinion in Lipidology · doi:10.1097/00041433-199404000-00006 · Cited by 209
Self-citation
Quantitative studies of transfer in vivo of low density, Sf 12-60, and Sf 60-400 lipoproteins between plasma and arterial intima in humans.
Shaikh, M., Wootton, R., Nordestgaard, B. G., Baskerville, P., Lumley, J. S., La Ville, A. E., Quiney, J., & Lewis, B. (1991) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.11.3.569 · Cited by 206
Rationale for Use of Non–High-Density Lipoprotein Cholesterol Rather Than Low-Density Lipoprotein Cholesterol as a Tool for Lipoprotein Cholesterol Screening and Assessment of Risk and Therapy
Frost, P. H., & Havel, R. J. (1998) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00034-4 · Cited by 193
Self-citation
Association of Remnant Lipoprotein Levels With Impairment of Endothelium-Dependent Vasomotor Function in Human Coronary Arteries
Kugiyama, K., Doi, H., Motoyama, T., Soejima, H., Misumi, K., Kawano, H., Nakagawa, O., Yoshimura, M., Ogawa, H., Matsumura, T., et al. (1998) · Circulation · doi:10.1161/01.cir.97.25.2519 · Cited by 187
Accumulation of large very low density lipoprotein in plasma during intravenous infusion of a chylomicron-like triglyceride emulsion reflects competition for a common lipolytic pathway.
Bjorkegren, J., Packard, C. J., Hamsten, A., Bedford, D., Caslake, M., Foster, L., Shepherd, J., Stewart, P., & Karpe, F. (1996) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37637-9 · Cited by 187
Properties of an apolipoprotein E-enriched fraction of triglyceride-rich lipoproteins isolated from human blood plasma with a monoclonal antibody to apolipoprotein B-100.
Campos, E. M., Nakajima, K., Tanaka, A., & Havel, R. (1992) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41527-5 · Cited by 185
Self-citation
The Role of Triglyceride-Rich Lipoprotein Families in the Progression of Atherosclerotic Lesions as Determined by Sequential Coronary Angiography From a Controlled Clinical Trial
Alaupovic, P., Mack, W. J., Knight‐Gibson, C., & Hodis, H. N. (1997) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.17.4.715 · Cited by 184
Lipoprotein clearance mechanisms in LDL receptor-deficient "Apo-B48-only" and "Apo-B100-only" mice.
Véniant, M. M., Zlot, C. H., Walzem, R. L., Pierotti, V., Driscoll, R. M., Dichek, D. A., Herz, J., & Young, S. G. (1998) · Journal of Clinical Investigation · doi:10.1172/jci4164 · Cited by 151
Triglyceride-Rich Lipoprotein Remnant Particles and Risk of Atherosclerosis
Hodis, H. N. (1999) · Circulation · doi:10.1161/01.cir.99.22.2852 · Cited by 149
Remnants of chylomicron and very low density lipoprotein impair endothelium-dependent vasorelaxation
Doi, H., Kugiyama, K., Ohgushi, M., Sugiyama, S., Matsumura, T., Ohta, Y., Nakano, T., Nakajima, K., & Yasue, H. (1998) · Atherosclerosis · doi:10.1016/s0021-9150(97)00291-8 · Cited by 121
Evaluation of an immunoseparation method for quantitative measurement of remnant-like particle-cholesterol in serum and plasma
Leary, E. T., Wang, T., Baker, D. J., Cilla, D. D., Zhong, J., Warnick, G. R., Nakajima, K., & Havel, R. J. (1998) · Clinical Chemistry · doi:10.1093/clinchem/44.12.2490 · Cited by 110
Self-citation
A macrophage receptor for apolipoprotein B48: Cloning, expression, and atherosclerosis
Brown, M. L., Ramprasad, M. P., Umeda, P. K., Tanaka, A., Kobayashi, Y., Watanabe, T., Shimoyamada, H., Kuo, W.-L., Li, R., Song, R., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.120184097 · Cited by 109
Susceptibility to atherosclerosis in mice expressing exclusively apolipoprotein B48 or apolipoprotein B100.
Véniant, M. M., Pierotti, V, Newland, D., Cham, C. M., Sanan, D. A., Walzem, R. L., & Young, S. G. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119511 · Cited by 100
Initial hepatic removal of chylomicron remnants is unaffected but endocytosis is delayed in mice lacking the low density lipoprotein receptor.
Herz, J., Qiu, S., Oesterle, A., deSilva, H., Shafi, S., & Havel, R. J. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.10.4611 · Cited by 98
Self-citation
Differences in postprandial concentrations of very—low-density lipoprotein and chylomicron remnants between normotriglyceridemic and hypertriglyceridemic men with and without coronary heart disease
Karpe, F., Hellénius, M.-L., & Hamsten, A. (1999) · Metabolism · doi:10.1016/s0026-0495(99)90076-8 · Cited by 97
Remnant-like Particle Cholesterol Levels in Patients with Dysbetalipoproteinemia or Coronary Artery Disease
Devaraj, S., Vega, G., Lange, R., Grundy, S. M., & Jialal, I. (1998) · The American Journal of Medicine · doi:10.1016/s0002-9343(98)00089-8 · Cited by 94
Book Review Comprehensive Clinical Nephrology By Richard J. Johnson and John Feehally. Approximately 700 pp., illustrated. St. Louis, Mosby, 2000. $189. 0-7234-3117-5
Kohler, H. J. (2000) · New England Journal of Medicine · doi:10.1056/nejm200006153422419 · Cited by 86
Chylomicron/chylomicron remnant turnover in humans: evidence for margination of chylomicrons and poor conversion of larger to smaller chylomicron remnants
Karpe, F., Olivecrona, T., Hamsten, A., & Hultin, M. (1997) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37219-9 · Cited by 80
Association of plasma triglyceride-rich lipoprotein remnants with coronary atherosclerosis in cases of sudden cardiac death
Takeichi, S., Yukawa, N., Nakajima, Y., Osawa, M., Saito, T., Seto, Y., Nakano, T., Saniabadi, A. R., Adachi, M., Wang, T., et al. (1999) · Atherosclerosis · doi:10.1016/s0021-9150(98)00246-9 · Cited by 79
Uptake of Remnant Like Particles (RLP) in Diabetic Patients from Mouse Peritoneal Macrophages
Tomono, S., Kawazu, S., Kato, N., Ono, T., Ishii, C., Ito, Y., Shimizu, M., Shimoyama, M., Nakano, T., & Nakajima, K. (1994) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat1994.1.98 · Cited by 76
Echolucent Carotid Artery Plaques Are Associated With Elevated Levels of Fasting and Postprandial Triglyceride-Rich Lipoproteins
Grønholdt, M.-L. M., Nordestgaard, B. G., Nielsen, T. G., & Sillesen, H. H. (1996) · Stroke · doi:10.1161/01.str.27.12.2166 · Cited by 74
Differences in apolipoprotein and lipid composition between human chylomicron remnants and very low density lipoproteins isolated from fasting and postprandial plasma
Björkegren, J., Karpe, F., Milne, R. W., & Hamsten, A. (1998) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32522-0 · Cited by 71
Improvement of endothelial vasomotor dysfunction by treatment with alpha-tocopherol in patients with high remnant lipoproteins levels
Kugiyama, K., Motoyama, T., Doi, H., Kawano, H., Hirai, N., Soejima, H., Miyao, Y., Takazoe, K., Moriyama, Y., Mizuno, Y., et al. (1999) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(99)00057-1 · Cited by 70
Influence of Diets Rich in Saturated and Omega-6 Polyunsaturated Fatty Acids on the Postprandial Responses of Apolipoproteins B-48, B-100, E, and Lipids in Triglyceride-Rich Lipoproteins
Bergeron, N., & Havel, R. J. (1995) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.15.12.2111 · Cited by 70
Self-citation
Accumulation of Apolipoprotein C-I–Rich and Cholesterol-Rich VLDL Remnants During Exaggerated Postprandial Triglyceridemia in Normolipidemic Patients With Coronary Artery Disease
Björkegren, J., Boquist, S., Samnegård, A., Lundman, P., Tornvall, P., Ericsson, C.-G., & Hamsten, A. (2000) · Circulation · doi:10.1161/01.cir.101.3.227 · Cited by 70
Apolipoprotein B-48 or Its Apolipoprotein B-100 Equivalent Mediates the Binding of Triglyceride-Rich Lipoproteins to Their Unique Human Monocyte-Macrophage Receptor
Gianturco, S. H., Ramprasad, M. P., Song, R., Li, R., Brown, M. L., & Bradley, W. A. (1998) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.18.6.968 · Cited by 70
Measurement of human apolipoprotein B-48 and B-100 kinetics in triglyceride-rich lipoproteins using [5,5,5-2H3]leucine.
Lichtenstein, A. H., Hachey, D., Millar, J., Jenner, J., Booth, L., Ordovás, J. M., & Schaefer, E. J. (1992) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41516-0 · Cited by 67
Effect of Statins on Metabolism of Apo-B–Containing Lipoproteins in Hypertriglyceridemic Men
Vega, G. L., & Grundy, S. M. (1998) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00036-8 · Cited by 63
Distinct murine macrophage receptor pathway for human triglyceride-rich lipoproteins.
Gianturco, S. H., Lin, A. H., Hwang, S. L., Young, J. B., Brown, S. A., Via, D. P., & Bradley, W. A. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113775 · Cited by 63
Fasting Remnant Lipoprotein Cholesterol and Triglyceride Concentrations Are Elevated in Nondiabetic, Insulin-Resistant, Female Volunteers
Abbasi, F., McLaughlin, T., Lamendola, C. A., Yeni-Komshian, H., Tanaka, A., Wang, T., Nakajima, K., & Reaven, G. M. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.11.6136 · Cited by 61
Characterization of remnant-like particles isolated by immunoaffinity gel from the plasma of type III and type IV hyperlipoproteinemic patients
Marcoux, C., Tremblay, M., Nakajima, K., Davignon, J., & Cohn, J. S. (1999) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32142-8 · Cited by 61
Membrane Active Lipids in Remnant Lipoproteins Cause Impairment of Endothelium-Dependent Vasorelaxation
Doi, H., Kugiyama, K., Ohgushi, M., Sugiyama, S., Matsumura, T., Ohta, Y., Oka, H., Ogata, N., Hirata, A., Yamamoto, Y., et al. (1999) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.19.8.1918 · Cited by 54
Plasma Lipoproteins Enhance Tissue Factor–Independent Factor VII Activation
Kjalke, M., Silveira, A. M. V., Hamsten, A., Hedner, U. K. E., & Ezban, M. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.7.1835 · Cited by 53
Impaired endothelium-dependent acetylcholine-induced coronary artery relaxation in patients with high serum remnant lipoprotein particles
Inoue, T., Saniabadi, A. R., Matsunaga, R., Hoshi, K., Yaguchi, I., & Morooka, S. (1998) · Atherosclerosis · doi:10.1016/s0021-9150(98)00098-7 · Cited by 50
Plasma remnant-like particle lipid and apolipoprotein levels in normolipidemic and hyperlipidemic subjects
Marcoux, C., Tremblay, M., Fredenrich, A., Jacques, H., Krimbou, L., Nakajima, K., Davignon, J., & Cohn, J. S. (1998) · Atherosclerosis · doi:10.1016/s0021-9150(98)00042-2 · Cited by 45
Ratio of remnant-like particle-cholesterol to serum total triglycerides is an effective alternative to ultracentrifugal and electrophoretic methods in the diagnosis of familial type III hyperlipoproteinemia.
Wang, T., Nakajima, K., Leary, E. T., Warnick, G. R., Cohn, J. S., Hopkins, P. N., Wu, L. L., Cilla, D. D., Zhong, J., & Havel, R. J. (1999) · PubMed · Cited by 45
Self-citation
Remnant-like lipoproteins stimulate whole blood platelet aggregation in vitro
Knöfler, R., Nakano, T., Nakajima, K., Takada, Y., & Takada, A. (1995) · Thrombosis Research · doi:10.1016/0049-3848(95)00044-5 · Cited by 41
Association of remnant-like particle cholesterol with coronary artery disease in patients with normal total cholesterol levels
Masuoka, H., Kamei, S., Wagayama, H., Ozaki, M., Kawasaki, A., Tanaka, T., Kitamura, M., Katoh, S., Shintani, U., Misaki, M., et al. (2000) · American Heart Journal · doi:10.1016/s0002-8703(00)90240-0 · Cited by 40
Remnant-like Particle-Cholesterol Concentrations in Patients with Type 2 Diabetes Mellitus and End-Stage Renal Disease
Hirany, S. V., O’Byrne, D., Devaraj, S., & Jialal, I. (2000) · Clinical Chemistry · doi:10.1093/clinchem/46.5.667 · Cited by 39
Predictive value of remnant-like particles cholesterol/high-density lipoprotein cholesterol ratio as a new indicator of coronary artery disease
Masuoka, H., Ishikura, K., Kamei, S., Obe, T., Seko, T., Okuda, K., Koyabu, S., Tsuneoka, K., Tamai, T., Sugawa, M., et al. (1998) · American Heart Journal · doi:10.1053/hj.1998.v136.89586 · Cited by 33
An increase of serum remnant-like particles in non-insulin-dependent diabetic patients with microalbuminuria
Shimizu, H., Mori, M., & SAITO, T. (1993) · Clinica Chimica Acta · doi:10.1016/0009-8981(93)90033-z · Cited by 31
IS ATHEROSCLEROSIS EXCLUSIVELY A POSTPRANDIAL PHENOMENON?
Mamo, J. C. L., Yu, K. C., Elsegood, C. L., Smith, D., Vine, D. F., Gennat, H. C., Voevodin, M., & Proctor, S. D. (1997) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.1997.tb01822.x · Cited by 27
Post-prandial lipaemia
Kirchmair, R., Ebenbichler, C. F., & Patsch, J. R. (1995) · Baillière s Clinical Endocrinology and Metabolism · doi:10.1016/s0950-351x(95)80081-6 · Cited by 16
Transient triglyceridemia in healthy normolipidemic men increases cellular processing of large very low density lipoproteins by fibroblasts in vitro
Björkegren, J., Karpe, F., Vitols, S., Tornvall, P., & Hamsten, A. (1998) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)33903-1 · Cited by 10

Research works printed but not linked: 4

Nakajima, 1997, J Clin Ligand Assay, 19, 177
Wang, 1999, Clin Chem, 45, 1981
Sekihara, 1996, Jp J Nephrol, 38, 220
Abbasi, 1999, J Clin Endocrinol Metab, 84, 3903

Sorted by citations

Thematic review series: The Pathogenesis of Atherosclerosis. Effects of infection and inflammation on lipid and lipoprotein metabolism mechanisms and consequences to the host
Khovidhunkit, W., Kim, M.-S., Memon, R. A., Shigenaga, J. K., Moser, A. H., Feingold, K. R., & Grunfeld, C. (2004) · Journal of Lipid Research · doi:10.1194/jlr.r300019-jlr200 · Cited by 1,481
Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies—a consensus statement from the European Atherosclerosis Society
Ginsberg, H. N., Packard, C. J., Chapman, M. J., Borén, J., Aguilar-Salinas, C. A., Averna, M., Ference, B. A., Gaudet, D., Hegele, R. A., Kersten, S., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab551 · Cited by 979
Japan Atherosclerosis Society (JAS) guidelines for prevention of atherosclerotic cardiovascular diseases 2017
Kinoshita, M., Yokote, K., Arai, H., Iida, M., Ishigaki, Y., Ishibashi, S., Umemoto, S., Egusa, G., Ohmura, H., Okamura, T., et al. (2018) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.gl2017 · Cited by 813
National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia: Part 1—Full Report
Jacobson, T. A., Ito, M. K., Maki, K. C., Orringer, C. E., Bays, H. E., Jones, P. H., McKenney, J. M., Grundy, S. M., Gill, E. A., Wild, R. A., et al. (2015) · Journal of clinical lipidology · doi:10.1016/j.jacl.2015.02.003 · Cited by 781
An International Atherosclerosis Society Position Paper: Global recommendations for the management of dyslipidemia
Grundy, S. M. (2013) · Journal of clinical lipidology · doi:10.1016/j.jacl.2013.10.001 · Cited by 353

See all 107

Authors: Havel, R. J.
Affiliations: University of California, San Francisco (US)
Corresponding author: Havel, Richard J.
Venue: Current Opinion in Lipidology
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 2000-12
Volume: 11
Issue: 6
Pages: 615-620
ISSN: 0957-9672 (ISSN-L)
DOI: 10.1097/00041433-200012000-00008
OpenAlex: W2084853272
Cited by: 107
References: 59
Citations by year: 2026: 2 · 2023: 4 · 2022: 2 · 2021: 3 · 2020: 2 · 2019: 6 · 2018: 6 · 2017: 2 · 2016: 1 · 2015: 3 · 2014: 4 · 2013: 7 · 2012: 3
FWCI: 1.58
Type: journal article
Language: en
Open access: closed
Locations: Current Opinion in Lipidology (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
Keywords: remnant lipoproteins, triglyceride-rich lipoproteins, atherogenic lipoproteins, macrophage uptake, chylomicron remnants, VLDL, postprandial lipemia, hypertriglyceridemia, atherosclerosis risk assessment, therapeutic target, lipid-lowering therapy
MeSH terms: Animals, Apolipoproteins B, Apolipoproteins E, Arteriosclerosis, Cholesterol Esters, Chylomicrons, Humans, Lipoproteins, Lipoproteins, HDL, Lipoproteins, VLDL, Macrophages, Triglycerides, Hypertriglyceridemia, Chylomicron Remnants

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Remnant lipoproteins as therapeutic targets

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks